AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 12.047
NA - Nord America 5.834
EU - Europa 2.294
SA - Sud America 843
OC - Oceania 56
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.134
Nazione #
HK - Hong Kong 9.005
US - Stati Uniti d'America 5.710
SG - Singapore 1.418
CN - Cina 713
BR - Brasile 692
IT - Italia 411
RU - Federazione Russa 399
VN - Vietnam 368
UA - Ucraina 347
DE - Germania 301
IE - Irlanda 217
TR - Turchia 185
SE - Svezia 155
KR - Corea 145
GB - Regno Unito 116
EE - Estonia 107
FI - Finlandia 73
CA - Canada 69
AR - Argentina 63
IN - India 48
BD - Bangladesh 33
EC - Ecuador 32
FR - Francia 32
JP - Giappone 31
AU - Australia 30
PL - Polonia 30
MX - Messico 29
ID - Indonesia 24
NZ - Nuova Zelanda 24
ES - Italia 19
ZA - Sudafrica 18
NL - Olanda 17
CZ - Repubblica Ceca 16
IQ - Iraq 15
PY - Paraguay 13
PK - Pakistan 12
VE - Venezuela 12
AT - Austria 10
CO - Colombia 10
IL - Israele 8
MA - Marocco 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
CL - Cile 7
KE - Kenya 7
PE - Perù 7
LT - Lituania 6
NP - Nepal 6
AL - Albania 5
EU - Europa 5
JM - Giamaica 5
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
ME - Montenegro 3
OM - Oman 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
IR - Iran 2
JO - Giordania 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TJ - Tagikistan 2
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
RO - Romania 1
RW - Ruanda 1
SI - Slovenia 1
Totale 21.131
Città #
Hong Kong 8.993
Ann Arbor 1.105
Singapore 656
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Dallas 403
Ashburn 300
Houston 255
Dublin 204
Woodbridge 201
Izmir 166
Beijing 160
Dong Ket 136
Nanjing 112
Moscow 110
Tallinn 107
Andover 104
Boardman 86
Ho Chi Minh City 77
Salerno 69
Munich 65
Pellezzano 64
São Paulo 62
Los Angeles 59
Düsseldorf 55
Hanoi 53
Norwalk 53
Dearborn 44
The Dalles 44
Shenyang 43
Nanchang 39
Naples 36
New York 35
Fairfield 34
Mestre 34
Hebei 29
Redwood City 26
Rio de Janeiro 26
Jiaxing 25
San Francisco 25
Warsaw 23
Montreal 22
Changsha 21
Rome 21
Pune 18
Santa Clara 18
Tianjin 18
Council Bluffs 17
Nuremberg 17
Boston 16
Brooklyn 16
Milan 16
San Diego 16
Tokyo 16
Washington 16
Haiphong 15
Atlanta 14
Casoria 14
Chennai 14
Guarulhos 14
Belo Horizonte 13
Poplar 13
Stockholm 13
Turku 13
Ankara 12
Brasília 12
London 12
Porto Alegre 12
Seoul 12
Amsterdam 11
Auckland 11
Curitiba 11
Frankfurt am Main 11
Guangzhou 11
Phoenix 11
Quito 11
Sydney 11
Campinas 10
Columbus 10
Denver 10
West Jordan 10
Dhaka 9
Guayaquil 9
Seattle 9
Cape Town 8
Chicago 8
Manchester 8
Ribeirão Preto 8
Salvador 8
Wuhan 8
Cambridge 7
Carapicuíba 7
Jinan 7
Johannesburg 7
Mexico City 7
Nairobi 7
Osasco 7
Santa Maria A Vico 7
Totale 16.732
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 964
Sex Differences in Parkinson’s Disease: From Bench to Bedside 630
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 586
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 577
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 523
Gender differences in microRNA expression in levodopa-naive PD patients 519
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 496
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 482
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 413
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 411
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 376
The most effective way to obtain long-term memory is to increase first presentation duration of single words 350
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 308
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 292
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 266
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 266
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 260
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 247
Classifying Different Stages of Parkinson’s Disease Through Random Forests 241
Metabolomics in Parkinson's disease 229
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 226
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 204
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 201
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 192
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 189
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 179
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 174
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 170
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 167
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 161
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 158
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 152
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 147
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 140
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 140
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 139
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 138
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 134
Increased bilirubin levels in de novo Parkinson's disease 130
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 128
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 126
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 126
Quitting smoking: An early non-motor feature of Parkinson's disease? 122
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 122
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 120
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 120
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 116
Clinical and neurological abnormalities in adult celiac disease. 115
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 115
Abnormal eating behaviors in progressive supranuclear palsy. 113
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 113
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 112
Freezing of gait and executive functions in patients with Parkinson’s disease 112
Machine learning can predict mild cognitive impairment in Parkinson's disease 111
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 111
Bisphenol A glucuronidation in patients with Parkinson's disease 108
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 108
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 106
Gender and non motor fluctuations in Parkinson's disease: A prospective study 104
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 102
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 101
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 100
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 98
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 95
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 94
“Response to Apomorphine in early Parkinson’s disease”. 94
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 94
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 93
Cognitive correlates of “pure apathy” in Parkinson's disease 93
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 92
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 91
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 90
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 90
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 89
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 88
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 88
Parkinson’s disease and the spectrum of Lewy body disease 88
Uric acid relates to dopamine transporter availability in Parkinson's disease. 87
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 87
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 87
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 87
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 85
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 85
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 83
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 83
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 82
Resting brain networks in patients with Parkinson's disease and freezing of gait 81
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 81
Gait patterns and cognition in Parkinson's disease 80
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 79
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 78
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 77
The "eye of the tiger" sign in pure akinesia with gait freezing. 77
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 77
Cognitive contributions to gait and falls: Evidence and implications 76
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 75
Hemi-restless legs syndrome induced by clebopride 75
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 75
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 74
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 74
Totale 17.410
Categoria #
all - tutte 64.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021495 0 0 0 0 0 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202611.870 1.587 4.538 3.992 682 920 151 0 0 0 0 0 0
Totale 21.531